JNGHF — Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
—
OTC ·
Unknown ·
Unknown ·
CIK 2071868 ·
China
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
No quarterly fundamentals indexed for this ticker.
Yahoo Snapshot (yfinance, live)
Total Revenue
$32,564,369,408
EBITDA
$9,452,852,224
Free Cash Flow
$6,307,738,624
Enterprise Value
$10,296,649,728
Total Cash
$40,635,797,504
Total Debt
$67,474,744
Shares Out
—
Trailing EPS
—
Book Value
$1.40
ROE
14.5%
ROA
8.8%
Div Yield
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| SPY | SPDR S&P 500 ETF TRUST | $692.88B | $754.95 | — |
| KLAC | KLA CORP | $302.43B | $231.52 | — |
| QQQ | INVESCO QQQ TRUST, SERIES 1 | $285.20B | $725.51 | — |
| IBM | INTERNATIONAL BUSINESS MACHINES CORP | $270.27B | $287.56 | — |
| KXIAY | Kioxia Holdings Corporation/ADR | $266.29B | $48.66 | — |
News headlines (Yahoo Finance, 1h cache)
Kailera Therapeutics (KLRA) is One of the Best IPO Stocks with Huge Upside Potential
2026-07-10 13:58 · Yahoo
Eli Lilly's Market Cap Balloons Again On This IPO's Setback
2026-07-07 20:09 · Yahoo
Update: Kailera Says Oral Small Molecule KAI-7535 Achieves Up to 11% Weight Loss in Phase 3 Trial; Shares Fall
2026-07-07 18:49 · Yahoo
Kailera points to Phase III oral obesity drug data as it tees up Foundayo rivalry
2026-07-07 14:59 · Yahoo
Kailera Says Oral Small Molecule KAI-7535 Achieves Up to 11% Weight Loss in Phase 3 Trial
2026-07-07 12:08 · Yahoo
Kailera says obesity pill succeeds in late-stage trial in China
2026-07-07 11:59 · Yahoo
Kailera Therapeutics Announces Positive Topline Data from Two Hengrui Pharma Phase 3 Clinical Trials of Oral Small Molecule GLP-1 Receptor Agonist HRS-7535/KAI-7535
2026-07-07 11:00 · Yahoo
Hengrui’s Heng Yi® Approved in China as an Innovative Cyclosporine Ophthalmic Solution for the Treatment of Dry Eye Disease
2026-06-30 05:00 · Yahoo
Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026
2026-06-05 23:32 · Yahoo
Kailera’s three-pronged obesity shot shows promise in early trial
2026-05-27 11:45 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.